• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将急性髓系白血病分化状态绘制在骨髓图谱上。

Putting AML Differentiation States on the BoneMarrowMap.

作者信息

Berger Jonas, Penter Livius

机构信息

Department of Hematology, Oncology, and Cancer Immunology, Campus Virchow Klinikum, Berlin, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Digital Clinician Scientist Program, Berlin, Germany.

出版信息

Blood Cancer Discov. 2025 Jul 1;6(4):280-283. doi: 10.1158/2643-3230.BCD-25-0083.

DOI:10.1158/2643-3230.BCD-25-0083
PMID:40294281
Abstract

This article presents a novel computational tool, "BoneMarrowMap," that enables the mapping of leukemic single-cell RNA sequencing datasets to hematopoietic differentiation states. By utilizing BoneMarrowMap for a large-scale single-cell RNA sequencing reanalysis, the authors discover 12 recurrent acute myeloid leukemia differentiation patterns linked to prognosis and treatment and dissect leukemic clonal architectures within individual patients. See related article by Zeng and colleagues, p. 307.

摘要

本文介绍了一种新型计算工具“骨髓图谱”,它能够将白血病单细胞RNA测序数据集映射到造血分化状态。通过利用骨髓图谱对大规模单细胞RNA测序进行重新分析,作者发现了12种与预后和治疗相关的复发性急性髓系白血病分化模式,并剖析了个体患者体内的白血病克隆结构。见曾及其同事的相关文章,第307页。

相似文献

1
Putting AML Differentiation States on the BoneMarrowMap.将急性髓系白血病分化状态绘制在骨髓图谱上。
Blood Cancer Discov. 2025 Jul 1;6(4):280-283. doi: 10.1158/2643-3230.BCD-25-0083.
2
Single-cell Transcriptional Atlas of Human Hematopoiesis Reveals Genetic and Hierarchy-Based Determinants of Aberrant AML Differentiation.人类造血的单细胞转录图谱揭示了异常急性髓系白血病分化的基于遗传和层级的决定因素。
Blood Cancer Discov. 2025 Apr 28:OF1-OF18. doi: 10.1158/2643-3230.BCD-24-0342.
3
Construction of a novel inflammatory-related prognostic signature of acute myelocytic leukemia based on conjoint analysis of single-cell and bulk RNA sequencing.基于单细胞和批量RNA测序联合分析构建急性髓细胞白血病新型炎症相关预后特征
Front Immunol. 2025 Jun 10;16:1565954. doi: 10.3389/fimmu.2025.1565954. eCollection 2025.
4
Single-cell transcriptional mapping reveals genetic and non-genetic determinants of aberrant differentiation in AML.单细胞转录图谱揭示了急性髓系白血病异常分化的遗传和非遗传决定因素。
bioRxiv. 2024 Nov 1:2023.12.26.573390. doi: 10.1101/2023.12.26.573390.
5
Cytarabine Pharmacogenomics and Outcomes Among Children and Young Adults With Acute Myeloid Leukemia.阿糖胞苷的药物基因组学与急性髓系白血病儿童及青年患者的预后
JAMA Netw Open. 2025 Jun 2;8(6):e2516296. doi: 10.1001/jamanetworkopen.2025.16296.
6
A novel bi-level meta-analysis approach: applied to biological pathway analysis.一种新型的双层次荟萃分析方法:应用于生物通路分析。
Bioinformatics. 2016 Feb 1;32(3):409-16. doi: 10.1093/bioinformatics/btv588. Epub 2015 Oct 14.
7
Single-cell sequencing applications in acute myeloid leukemia.单细胞测序在急性髓系白血病中的应用
Leuk Lymphoma. 2025 Feb;66(2):175-189. doi: 10.1080/10428194.2024.2422833. Epub 2024 Nov 4.
8
Targeting ferritinophagy impairs quiescent cancer stem cells in acute myeloid leukemia in vitro and in vivo models.靶向铁蛋白自噬可体外和体内模型中削弱急性髓系白血病的静止癌症干细胞。
Sci Transl Med. 2024 Jul 24;16(757):eadk1731. doi: 10.1126/scitranslmed.adk1731.
9
Artificial intelligence approaches for tumor phenotype stratification from single-cell transcriptomic data.基于单细胞转录组数据的肿瘤表型分层的人工智能方法
Elife. 2025 Jun 13;13:RP98469. doi: 10.7554/eLife.98469.
10
The dual effect of interferon-γ in acute myeloid leukemia: A narrative review.干扰素-γ在急性髓系白血病中的双重作用:一篇叙述性综述。
Semin Oncol. 2025 Jun;52(3):152347. doi: 10.1016/j.seminoncol.2025.152347. Epub 2025 May 5.

本文引用的文献

1
Single-cell Transcriptional Atlas of Human Hematopoiesis Reveals Genetic and Hierarchy-Based Determinants of Aberrant AML Differentiation.人类造血的单细胞转录图谱揭示了异常急性髓系白血病分化的基于遗传和层级的决定因素。
Blood Cancer Discov. 2025 Apr 28:OF1-OF18. doi: 10.1158/2643-3230.BCD-24-0342.
2
Tracking Rare Single Donor and Recipient Immune and Leukemia Cells after Allogeneic Hematopoietic Cell Transplantation Using Mitochondrial DNA Mutations.使用线粒体 DNA 突变追踪异基因造血细胞移植后罕见的供体和受体免疫及白血病细胞。
Blood Cancer Discov. 2024 Nov 1;5(6):442-459. doi: 10.1158/2643-3230.BCD-23-0138.
3
Integrative genotyping of cancer and immune phenotypes by long-read sequencing.
基于长读测序的癌症和免疫表型的综合基因分型。
Nat Commun. 2024 Jan 2;15(1):32. doi: 10.1038/s41467-023-44137-7.
4
Clonally resolved single-cell multi-omics identifies routes of cellular differentiation in acute myeloid leukemia.克隆解析单细胞多组学鉴定急性髓系白血病细胞分化途径。
Cell Stem Cell. 2023 May 4;30(5):706-721.e8. doi: 10.1016/j.stem.2023.04.001. Epub 2023 Apr 24.
5
Unified classification and risk-stratification in Acute Myeloid Leukemia.急性髓系白血病的统一分类和危险分层。
Nat Commun. 2022 Aug 8;13(1):4622. doi: 10.1038/s41467-022-32103-8.
6
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.急性髓系白血病药物反应与临床结局的综合分析。
Cancer Cell. 2022 Aug 8;40(8):850-864.e9. doi: 10.1016/j.ccell.2022.07.002. Epub 2022 Jul 21.
7
Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia.单核细胞亚克隆赋予急性髓系白血病患者对 Venetoclax 为基础治疗的耐药性。
Cancer Discov. 2020 Apr;10(4):536-551. doi: 10.1158/2159-8290.CD-19-0710. Epub 2020 Jan 23.
8
Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity.单细胞 RNA-Seq 揭示与疾病进展和免疫相关的 AML 层次结构。
Cell. 2019 Mar 7;176(6):1265-1281.e24. doi: 10.1016/j.cell.2019.01.031. Epub 2019 Feb 28.
9
Human haematopoietic stem cell lineage commitment is a continuous process.人类造血干细胞谱系定向分化是一个连续的过程。
Nat Cell Biol. 2017 Apr;19(4):271-281. doi: 10.1038/ncb3493. Epub 2017 Mar 20.
10
Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis.急性髓系白血病的数据驱动表型剖析揭示了与预后相关的祖细胞样细胞。
Cell. 2015 Jul 2;162(1):184-97. doi: 10.1016/j.cell.2015.05.047. Epub 2015 Jun 18.